Articles related to BLEEDING/BLOOD DISORDERS

In a comprehensive Bayesian network meta-analysis, 1 month of DAPT followed by potent P2Y12 inhibitor monotherapy was associated with a significant reduction in major bleeding compared to the conventional 12 months of DAPT, without an increase in MACCE.

Valoctocogene roxaparvovec gene therapy demonstrates long-term efficacy in reducing bleeding episodes and factor VIII use in patients with severe hemophilia A, potentially changing the treatment landscape for this condition.

In patients with both cirrhosis and atrial fibrillation, apixaban initiation was associated with lower rates of major bleeding compared to rivaroxaban or warfarin, without compromising thromboembolic protection.

Schistosomiasis should be considered in the differential diagnosis for patients presenting with rectal bleeding, particularly those with a history of freshwater exposure in endemic areas.

Pantoprazole demonstrated a significant reduction in upper gastrointestinal bleeding in mechanically ventilated ICU patients, offering a viable prophylactic option without impacting overall mortality rates.

Red-cell rosette formation in malaria may allow infected erythrocytes to evade splenic sequestration, posing challenges in treatment.